Abstract
Critical appraisal of a scientific trial involves deciding on its internal validity—
whether the hypothesis has been correctly accepted or rejected—and its external validity—the
extent to which the trial's findings can be generalized. Discourse on homoeopathic
research has focused on the former at the expense of the latter and an analysis of
homoeopathic research demonstrates that it has low external validity. One solution
would be to split the research process in two. Large scale, triple-blind trials could
be used to determine the extent to which the action of homoeopathy may be explained
by placebo. Importantly, no assessment of external validity would be made. Audit and
cohort studies could then be used to examine questions usually associated with external
validity, such as the conditions most suitable for treatment and the long-term clinical
value of homoeopathy.